Dalal Street Tower Talk

Archies (Rs. 24.00) (Code: 532212) :- After a sharp correction, the share looks attractively priced at current levels. Some HNIs and value investors are keeping a close eye on the stock. The company is expected to do well in the upcoming festival season. The stock can deliver good returns in the short term.

Oricon Enterprise (Rs. 56.00) (Code: 513121) :- The share of this multi division company, which has businesses in marine logistics, packaging and realty, has become circuit breakers. According to reports, Oricon Enterprise's subsidiary has received nod from BMC for developing residential project on 2 acre land in Mumbai. The company has invested Rs. 159 crores in the subsidiary for 100% equity, and it is presently valued at Rs. 400 crores. The company is also said to be forming a JV with a leading Mumbai-based developer.

Godrej Properties (Rs. 323.00) (Code: 533150) :- This realty sector share is the favourite of HNIs and institutions. The company is expected to benefit significantly from a potential rate cut by the Reserve Bank. The unchanged interest rates by US Fed, low inflation and macro economic data suggest that RBI would cut rates in its ensuing meeting.

SpiceJet (Rs. 25.00) (Code: 500285) :- ATF prices have fallen by as much as 40% in recent months and are expected to slide further. The company is benefiting from high occupancy rate in aviation sector. It is also expected to benefit from the new civil aviation policy which is in the offing. The stock is expected to soar high as rival Indigo enters the capital markets with its IPO in October.

Comments

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News* *TCI FINANCE LTD (501242 & NSE) (31)* Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc. The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services. *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...

Value Research

Search This Blog